Treffer 1 - 5 von 5 für Suche 'Seyed Reza Mousavi (13223324)', Suchdauer: 0,01s Treffer weiter einschränken
  1. 1
    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites.

    The non-inferiority margin in Phase III clinical trial of SnaFab compared to Razi antivenom in snakebites. von Seyed Reza Mousavi (13223324)

    Veröffentlicht 2025
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58].

    Snakebite severity classification in clinical trial of SnaFab vs. Razi antivenom in snakebite victims [14,57,58]. von Seyed Reza Mousavi (13223324)

    Veröffentlicht 2025
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites.

    Adverse events during follow-up period in Phase III non-inferiority clinical trial of SnaFab compared to Razi antivenom in snakebites. von Seyed Reza Mousavi (13223324)

    Veröffentlicht 2025
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Consort Chart of Phase III clinical trial of SnaFab compare to Razi antivenom in snakebites. von Seyed Reza Mousavi (13223324)

    Veröffentlicht 2025
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites.

    Demographic information and clinical presentation of victims in Phase III non-inferiority clinical trial of SnaFab compare to Razi antivenom in snakebites. von Seyed Reza Mousavi (13223324)

    Veröffentlicht 2025
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: